HERON THERAPEUTICS, INC. /DE/ Inventory
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Inventory of $90.58 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-10
- 2026-06-30: Inventory, Net $90.58M.
- 2026-03-31: Inventory, Net $92.54M.
- 2025-12-31: Inventory, Net $92.75M.
- 2025-09-30: Inventory, Net $70.03M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $90.58M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $92.54M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $92.75M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $70.03M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $72.97M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $56.93M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $53.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $45.95M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $42.86M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $42.47M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $42.11M 10-K · filed 2025-02-27 |
| 2023-09-30 | $42.01M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $44.62M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $52.06M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $54.57M 10-K · filed 2024-03-12 |
| 2022-09-30 | $52.24M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $61.32M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $56.47M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $48.38M 10-K · filed 2023-03-29 |
| 2021-09-30 | $41.50M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $42.80M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $42.63M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $41.91M 10-K · filed 2022-02-28 |
| 2020-09-30 | $42.75M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $41.44M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $34.85M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $24.97M 10-K · filed 2021-02-24 |
| 2019-09-30 | $24.17M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $29.27M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $31.42M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $39.03M 10-K · filed 2020-03-02 |
| 2018-09-30 | $31.41M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $27.20M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $19.42M 10-Q · filed 2018-05-10 |
| 2018-01-01 | $9.91M 10-K · filed 2019-02-22 |
| 2017-12-31 | $10.11M 10-K · filed 2020-03-02 |
| 2017-09-30 | $5.17M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $4.80M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.64M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.34M 10-K · filed 2018-02-27 |
| 2016-09-30 | $1.98M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $3.31M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $2.74M 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |